Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by High Katherine A, Director. Director active across 1 company, notably INCYTE CORP. In total, 5 disclosures have been published. History available since 26 May 2021. The latest transaction was disclosed on 12 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations
Katherine A. High serves as a Director at Incyte Corp. As a board member, she contributes to overseeing the company's operations and shaping its strategy. Katherine brings valuable expertise in the biopharmaceutical sector, helping Incyte innovate and grow. Her commitment to corporate governance is essential for ensuring transparency and accountability.